Molecular Imaging Seminar Dec 2012 Dr. Rao Papineni : Imaging in vivo ROS Activity in Inflammation and Cancer
3rd International Cancer Research Symposium 2012
Defining & Translating Science for Disease Prevention and Therapy
Venue: SWISSOTEL
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata-700157, West Bengal, India
19 - 21 December, 2012 Topics to be addressed :
(a) Application of Emerging Technologies in Cancer Research (b) Genetic and Epigenetic Mechanisms in the Pathobiology of Cancer (c) Novel Therapies (Immuno-and Stem Cell-based Therapies) (d) Complementary and Alternative Approaches for Cancer Prevention and Therapy
Organizing Committee (USA) Sushanta K. Banerjee (Chair)
C.V.Rao ,(Co-Chair) Rajesh Agarwal , (Co-Chair) Shivendra Singh , (Co-Chair)
Organizing Committee (India)
Dhrubajyoti Chattopadhyay (Chair) Gopal Kundu (Co Chair) Bhudev C Das (Co-Chair)
Secretaries Organizing Committee Gaurisankar Sa (Secretary)
Urmi Chatterji (Secretary)
Treasurer Alok Kumar Sil
Nitai Bhattacharyya Tanya Das Chinmay Panda Deepak Mishra
Sharmila Sengupta Mrinal Ghosh Diptendra Sarkar
Contact USA INDIA
Joi Wickliffe [email protected] Tel: 816-861-4700x57922
Atanu Roy Chowdhury [email protected] Tel: 2335-0067
3rd International Cancer Research Symposium 2012
Defining & Translating Science for Disease Prevention and Therapy 19-21 December, 2012
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat Kolkata, West Bengal 700157, India
The Registration Fee (along with the Registration Form) has to be paid as follows:
• Payment through Demand Draft, multicity account payee cheque or Money Transfer / National Electronic Fund Transfer (NEFT/RTGS) only. • Demand draft or multicity account payee cheque should be drawn in favour of “3rd ICRS 2012” payable at Kolkata (Registration will be confirmed after realization of cheques). • Money transfer/NEFT/RTGS (Inter-Bank Transfer): State Bank of India, Calcutta University Branch, IFSC Code SBIN0007766, A/C No. 32470598175. • Money transfer can also be done through Internet Banking. • Wire transfer for Foreign Remittance through SWIFT Code SBININBB106 • Please write your name and address on the back of the Bank Draft without fail and also enclose three stamp size photographs
Address for correspondence: Prof. D. J. Chattopadhyay
Director, Centre for Research in Nanoscience and Nanotechnology JD-2, Sector-III, Salt Lake, Kolkata-700 098, West Bengal
Telephone : +91 +033-2335 0067 / Fax : +91 +033-2257 1470 E-mail: [email protected]
Website : http://www.3rdicrs2012.org
Last Date of Registration: 15 October, 2012
Completed registration forms and abstracts (if applicable) should be mailed to: [email protected]
ABSTRACTS should be 2000 characters or less with space and have a title, author’s names (presenting author’s name underlined), place of work, contact telephone number and email address. The abstract should have an Introduction, Material and Methods, Results and a Conclusion Section. The authors should indicate in the registration form whether they prefer to make a Poster or Oral presentation.
3rd International Cancer Research Symposium 2012
Defining & Translating Science for Disease Prevention and Therapy 19-21 December, 2012
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata, West Bengal 700157, India
First name, Surname
Prof./ Dr./ Mr./ Ms. Prefix
Gender Male Female
Faculty/ Clinician
PDF Scholar
Department
Institution Address
City State Country
PIN Tel # Cell #
FAX Email
Indian NRI Foreign Nationality
Category of Participation
NO YES Submitting abstract? If yes, ORAL POSTER
Registration Students and PDFs Faculty and Clinicians
15 October, 2012 Rs. 1,500 Rs. 3,000
Spot registration Rs. 2,500 Rs. 5,000
Invited Speaker Young Scientist Delegate General
NON-VEG VEG Food preference
cv
SPEAKER TITLE
*(TBA-to be announced, presenter has yet to provide a title)
1. Addanki Pratap Kumar , Ph.D (USA)
Translation of complementary and alternate
medicinal modalities from bench to bedside.
2. Adhip N Majumdar, Ph.D. (USA)
Cancer Stem Cells: Implications for Colorectal
Carcinogenesis and Development of Therapeutic
Strategies
3. Ajay Rana, Ph.D. (USA)
Mixed Lineage Kinases: Novel Therapeutic Targets
of Proliferative and Degenerative Diseases
4. Alakananda Basu, Ph.D. (USA)
Targeting AGC Kinases in Breast Cancer
5. Alo Nag, Ph.D. (IND)
Combating Cancer Through Discovery of Novel
Molecular Targets.
6. Alok De, Ph.D. (USA)
Prevents Ovarian Carcinogenesis by Amla
7. Amitava Chatterjee, Ph.D. (IND)
MMP-2 a potential marker of breast cancer
8. Andrew Leask, Ph.D. (CAN)
Managing the microenvironment: matricellular
adhesive proteins as signaling modulators in skin
9. Anuradha Sehrawat, PhD (USA)
Inhibition of Epithelial-Mesenchymal
Transition by Benzyl Isothiocyanate, A
Cruciferous Vegetable-Derived Cancer
Chemopreventive Agent
10. Arun Kumar Sharma, Ph.D. (USA)
Developing selenium based cancer
therapeutics
11. Bandana Chatterjee, Ph.D. (USA)
Targeting Intra tumor Androgen Signaling in
Prostate Cancer via Enzymatic Sulfation: A Nuclear
Receptor-directed Novel Treatment Approach
12. Barbara Dunn, Ph.D. (USA)
Update of Clinical Trials in Breast Cancer
13. Bhudev Das, Ph.D. (IND)
TBA
14. Bimal Ray, Ph.D. (USA)
Targeting a Novel Epigenetic Regulatory
Mechanism for Breast Cancer
15. C.V. Rao, Ph.D. (USA)
Transcriptomic Approaches: Prevention and
Treatment of GI Cancers
16. Chandi Charan Mandal, Ph.D. (USA)
A Cholesterol-lowering Drug Targets
Osteoclastogenic Factors to Prevent Osteolytic
Bone Metastasis of Breast Cancer
17. Chandrani Sarkar, Ph.D. (USA)
TBA
18. Charles Giardina, Ph.D. (USA)
New experimental approaches for identifying
novel colon cancer chemopreventive agents
19. Chendil Damodaran, Ph.D (USA)
Modulating AKT induced Epithelial Mesenchymal
Transition for Prevention and Treatment of Colon
Cancer
20. Chimnay Kumar Panda, Ph.D. (IND)
Molecular analysis of cellular pathways associated
with the development of uterine cervical
carcinoma
21. Dipak Banerjee, Ph.D. (USA-PR)
Tunicamycin Inhibits Angiogenesis and Prevents
Breast Cancer Progression
22. Dipak Sarkar, Ph.D. (USA)
Current Research Work on Role of beta-endorphin
in Cancer Prevention
23. Dulal Panda, Ph.D. (IND)
TBA
24. Ellora Sen, Ph.D. (IND)
Tumor necrosis factor (TNFa) regulates
radioresistance in glioblastoma
25. Ernest Hawk, MD (USA)
Clinical Agent Development for CRC Prevention.
26. Gopal Chakrabarti, Ph.D. (IND)
Targeted Drug Development: Synthetic thiadiazole
NMK-TD-100, a novel microtubule modulating
agent, induces apoptosis and autophagy in cancer
cells.
27. Gopal Kundu, Ph.D. (IND) Osteopontin and Related Proteins: Role in
Inflammation, Cancer and Pathological
Angiogenesis
28. Goutam Ghosh–Choudhury, Ph.D.
(USA)
MicroRNAs in renal cancer and tumor suppressor
protein PTEN".
29. Hari Koul, Ph.D. (USA)
Sam Pointed Domain Transcription Factor: A
New Tumor Metastasis Suppressor
30. Jamboor Vishwanatha, Ph.D. (USA)
Reciprocal Regulation of Her-2 and Annexin A2
in Breast Cancer
31. James W. Freeman, Ph.D. (USA)
Molecular Targets for Therapy of the
Chemoresistant/Stem Cell Phenotype in
Pancreatic Cancer.
32. Joan Cunningham, Ph.D. (USA)
Using massage therapy to treat chemotherapy-
induced peripheral neuropathy
33. Kapil Mehta, Ph.D. (USA)
Targeting Inflammation to Prevent Cancer
Progression
34. Kattesh V. Katti, Ph.D. (USA)
How can we achieve tumor staurticity of fast
growing and inoperable metastatic Cancers
35. Lester F. Lau, Ph.D. (USA)
The Matricellular Protein CCN1 in Inflammatory
Diseases and Cancer
36. Lucio Miele, MD, Ph.D. (USA)
Development of Notch inhibitors in breast cancer:
targeting stem cell pathways
37. Mahitosh Mandal (IND)
The potential of celecoxib-loaded hydroxyapatite-
chitosan nanocomposite for the treatment of
colon cancer
38. Mausumi Bharadwaj, Ph.D. (IND)
The genetic and epigenetic regulation of
carcinogenesis in Human Papilloma Virus assoc.
epithelial cancer
39. Michael J. Wargovich, (USA)
Epigenetic Mechanisms in the Chemoprevention
of Colon Cancer by Tea Polyphenol, EGCG
40. Ming You, MD (USA)
TBA
41. Mohamed Saleem (Bhat), Ph.D (USA)
Strategies to Tame the Activities of Androgen
Receptor for Treating Androgen-independent
Prostate Cancer
42. Mrinal Kanti Ghosh, Ph.D. (IND)
Area on basic mechanistic understanding of cancer
cell signaling and crosstalk
43. Nandini Ghsh-Choudhury ,Ph.D. (USA)
Omega 3 Fatty Acids Differentially Target
OncomiRs and Tumor Suppressor micro-RNAs to
Prevent Breast Cancer Metastasis
44. Neil Bhowmick, PhD (USA)
Targeted therapeutics require tumor
microenvironment considerations
45. Nitai P. Bhattacharyya, Ph.D. (IND) TBA
46. Ossama Tawfik, MD, Ph.D. (USA)
What Does a Pap Smear Have to do with
Telepathology? TelePAPology the New Kid on the
Block!!
47. Pamela Munster, MD, Ph.D. (USA)
Reversal of hormone therapy resistance by
epigenetic modulation
48. Partha P. Majumdar, Ph.D. (IND)
GENOMIC ALTERATIONS IN GINGIVO-BUCCAL
ORAL CANCER, IDENTIFIED BY MASSIVELY-
PARALLEL DNA SEQUENCING
49. Peeyush Lala, MD, Ph.D (CAN)
COX-2 and COX-2 induced miRNAs in breast cancer
progression: sustenace of Stem-like cells
50. Peter Van Velduizen, MD (USA)
Prostate Cancer: New Paradigms and
Approaches to Active Surveillance
51. Prasanta Banerji (IND) and Pratip
Banerji ,MD (IND)
The Banerji Protocols: The Regression of Malignant
Tumors by a Non-Toxic and Non-Invasive Oral
Medical Approach
52. Priyabrata Mukherjee , Ph.D. (USA)
Nanomedicine: Opportunities and Challenges in
Cancer Therapy
53. Raj K. Tiwari, Ph.D. (USA)
Cancer Vaccines : Evolving Paradigms
54. Rajagopal Ramesh, Ph.D. (USA)
TUSC2/FUS1-gene-based nanotherapy for lung
cancer: From Mice to Humans
55. Rajendra G. Mehta, Ph.D (USA)
Deguelin as a possible chemopreventive and
therapeutic agent for breast cancer
56. Rajesh Agarwal, Ph.D. (USA)
Epigenetic Mechanisms Contributing to the Anti-
cancer Efficacy of Silibinin in Non-small Cell Lung
Cancer
57. Rajkumar Lakshmanaswamy, Ph.D.
(USA)
Pregnancy, Hormones, and Breast Cancer
58. Rao Papineni, Ph.D. (USA)
Imaging in vivo ROS Activity in Inflammation and
Cancer – A non invasive approach
59. Ratna Chakrabarti , Ph.D. (USA)
Actin cytosketon modulatory protein LIM kinase 1
and functional regulation of MT1-MMP:
Implication in invasion of prostate cancer cells
60. Ratna Ray, Ph.D. (USA)
Prostate Cancer: Potential for Prevention and
Therapy
61. Richard Eckert, Ph.D.(USA)
Polycomb Genes, chemoprevention and skin
cancer response to cell stress
62. Rita Mulherker, Ph.D. (IND)
Gene Therapy for Head and Neck cancer: From lab
to Clinics
63. Robert Sclafani, Ph.D. (USA)
Molecular Mechanism of Cancer Chemoprevention
by Resveratrol.
64. Rod Dashwood (USA)
Epigenetics, diet, and cancer: Convergence of
histone marks, DNA methylation, and miRNA
profiling in chemoprevention studies
65. Roy Jensen, MD (USA)
Overcoming BRCA1 Mediated Chemotherapeutic
and Radiation Resistance in Cancer
66. Samarendra N. Banerjee, Ph.D (IND)
Anti-angiogenic therapy on in vivo tumor bearing
mouse model System
67. Sanjay Gupta, Ph.D. (USA)
PLANT FLAVONOIDS AS EPIGENETIC MODULATORS
IN CANCER: IMPLICATIONS IN CANCER
CHEMOPREVENTION
68. Sankar Mitra, Ph.D (USA)
TBA
69. Sen Pathak, Ph.D. (USA)
Are telomeres involved in Cancer causation, drug
discovery and prevention?
70. Shailesh Singh (USA)
TBA
71. Sharmila Sengupta, Ph.D (IND)
TBA
72. Sheo Mohan Singh, Ph.D. (IND)
Role of myeloid transcription factors in the
pathogenesis of leukemic cancers
73. Shivendra Singh , Ph.D. (USA)
TBA
74. Shrikant Anant , Ph.D. (USA)
TBA
75. Snigdha Banerjee, Ph.D. (USA)
The role of PDGF-B-NRP-1 signaling in
mesenchymal to pericytes transition during tumor
angiogenesis
76. Soumen Paul, Ph.D. (USA)
Protein Kinase C Signaling: from Embryonic Stem
Cell to Cancer
77. Subash Basu ,PhD, D.Sc (USA)
Probable New Therapeutic Drugs for Breast and
Colon Cancers
78. Subhamoy Dasgupta, PhD (USA)
Steroid Receptor Coactivator in Oncogenic
Reprogramming of Cancer Cell Metabolism.
79. Sujit Basu, MD, Ph.D. (USA)
TBA
80. Suman Kambhampati, MD (USA)
A Second Generation 2-Methoxyestradiol Prodrug
is Effective against Barrett’s Adenocarcinoma in a
Mouse Xenograft Model
81. Sushanta K. Banerjee, Ph.D (USA)
Aspirin in breast carcinogenesis: A friend or foe
82. Tanya Das, Ph.D (IND)
Targeting cancer stem cells: An approach towards
next generation cancer therapy
83. Tapan Chaudhuri, MD (USA)
Introduction to the science of acupuncture and its
application in the realm of Cancer
84. Tapas Kundu, Ph.D (IND)
Epigenetic Modifications as Targets of Cancer
Therapeutics: Implications in Oral Cancer.
85. Thangarajan Rajkumar, Ph.D. (IND)
Targeting EWS-FLT1 fusion protein
86. Theresa Pacheco, Ph.D (USA)
TBA
87. Tony Kong, MD (USA)
Cancer Prevention by Dietary Phytochemicals:
from Nrf2-mediated Anti-Oxidative Stress,
Epigenetics to in vivo Cancer Models
88. Uddhav Kelavkar, PhD
(USA)
Dietary polyunsaturated fatty acids, cancer and
chemoprevention
89. Urmi Chatterji, Ph.D (IND)
Elucidating the molecular signaling adapted by
artemisinin in cervical cancer cells
90. Virginia Savin, MD(USA)
Evaluating renal function in patients
undergoing chemotherapy
91. Xianglin Shi , MD, Ph.D (USA)
Plant-derived antioxidants and disease prevention
92. Xiaolin Zi , PhD (USA)
Epigenetic chemoprevention of tobacco-related
urinary bladder carcinogenesis by Kawain
93. Yogesh C Awasthi, PhD (USA)
TBA